Cystic fibrosis: Treatment with a supercomputer drug delivery model

Advances in Engineering Software

Volumn 28, Issue 6, 1997, Pages 359-364

  Martonen, T B ^a,b   Hwang, D ^c,g   Katz, I ^d   Yang, Y ^e   Guan, X ^f  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c MCNC   (United States)

^d TRINITY UNIVERSITY   (United States)

^e BellSouth   (United States)

^f DUKE UNIVERSITY   (United States)

^g IBM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER SIMULATION; DRUG PRODUCTS; DRUG THERAPY; MATHEMATICAL MODELS; PATIENT TREATMENT; RESPIRATORY THERAPY; THREE DIMENSIONAL; CONTROLLED DRUG DELIVERY; PULMONARY DISEASES; SUPERCOMPUTERS; THREE DIMENSIONAL COMPUTER GRAPHICS;

AIRSTREAM PATTERNS; CYSTIC FIBROSIS; DRUG DELIVERY MODEL; CYSTIC FIBROSIS (CF); SUPERCOMPUTER DRUG DELIVERY MODEL;

SUPERCOMPUTERS; COMPUTER AIDED DIAGNOSIS;

EID: 0031195596     PISSN: 09659978     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0965-9978(97)00014-8     Document Type: Article

References (26)

1. Gerken, T. A. and Gupta, R., Mucus in cystic fibrosis. In Cystic Fibrosis, ed. P. B. Davis. Marcel-Dekker, New York, 1993, pp. 53-90.
2. Davis, P. B. (ed.), Cystic Fibrosis. Marcel-Dekker, New York, 1993.
3. Kavanaugh, R. E., Unadkat, J. D. and Smith, A. L., Drug disposition in cystic fibrosis. In Cystic Fibrosis, ed. P. B. Davis. Marcel-Dekker, New York, 1993, pp. 91-136.
4. Iannuzzi, M. C., Cystic fibrosis: genetics. In Cystic Fibrosis, ed. P. B. Davis. Marcel-Dekker, New York, 1993, pp. 1-27.
5. Turpin, S. V. and Knowles, M. R., Treatment of pulmonary disease in patients with cystic fibrosis. In Cystic Fibrosis, ed. P. B. Davis. Marcel-Dekker, New York, 1993, pp. 277-344.
6. Stern, R. C., Pulmonary complications. In Cystic Fibrosis, ed. P. B. Davis. Marcel-Dekker, New York, 1993, pp. 345-380.
7. Stern, R. C., Cystic fibrosis and the reproductive system. In Cystic Fibrosis, ed. P. B. Davis. Marcel-Dekker, New York, 1993, pp. 381-400.
8. Stern, R. C., Cystic fibrosis and the gastrointestinal tract. In Cystic Fibrosis, ed. P. B. Davis. Marcel-Dekker, New York, 1993, pp. 401-434.
9. Davis, P. B., Pathophysiology of the lung disease in cystic fibrosis. In Cystic Fibrosis, ed. P. B. Davis. Marcel-Dekker, New York, 1993, pp. 193-218.
10. Weibel, E. R., Morphometry of the Human Lung. Academic Press, New York, 1963.
11. Weibel, E. R., Design of airways and blood vessels as branching trees. In The Lung: Scientific Foundations, Vol. 1, ed. R. G. Crystal et al. Raven Press, New York, 1991, pp. 711-720.
12. Horsfield, K., Pulmonary airways and blood vessels considered as confluent trees. In The Lung: Scientific Foundations, Vol. 1, ed. R. G. Crystal et al. Raven Press, New York, 1991, pp. 721-727.
13. Martonen, T. B., On the fate of inhaled particles in the human: a comparison of experimental data with theoretical computations based on a symmetric and asymmetric lung. Bulletin of Mathematical Biology, 1983, 45, 409-424.
14. Martonen, T. B., Mathematical model for the selective deposition of inhaled pharmaceuticals. Journal of Pharmaceutical Sciences, 1993, 82, 1191-1199.
15. Martonen, T. B. and Katz, I., Deposition patterns of polydisperse aerosols within human lungs. Journal of Aerosol Medicine, 1993, 6, 251-274.
16. Martonen, T. B. and Katz, I. M., Deposition patterns of aerosolized drugs within human lungs: effects of ventilatory parameters. Pharmaceutical Research, 1993, 10, 871-878.
17. Martonen, T. B. and Katz, I. M., Inter-related effects of morphology and ventilation on drug deposition patterns. S.T.P. Pharma Sciences, 1994, 4, 11-18.
18. Martonen, T. B., Graham, R. C. and Hofmann, W., Human subject age and activity level: factors addressed in a biomathematical deposition program for extrapolation modeling. Health Physics, 1989, 57, 49-59.
19. Hofmann, W., Martonen, T. B. and Graham, R. C., Predicted deposition of nonhygroscopic aerosols in the human lung as a function of subject age. Journal of Aerosol Medicine, 1989, 2, 49-68.
20. Martonen, T. B., Aerosol therapy implications of particle deposition patterns in simulated human airways. Journal of Aerosol Medicine, 1991, 4, 25-40.
21. Raabe, O. G., Particle size analysis utilizing grouped data and the lognormal distribution. Journal of Aerosol Science, 1971, 2, 289-303.
22. Martonen, T. B., Yang, Y. and Xue, Z. Q., Influences of cartilaginous rings on tracheobronchial fluid dynamics. Inhalation Toxicology, 1994, 6, 185-203.
23. Martonen, T. B., Yang, Y. and Xue, Z. Q., Effects of carinal ridge shapes on lung airstreams. Aerosol Science & Technology, 1994, 21, 119-136.
24. Sabersky, R. H., Acosta, A. J. and Hauptmann, E. G., Fluid Flow, A First Course in Fluid Mechanics, 3rd edn. Macmillan, New York, 1989.
25. Martonen, T. B., Analytical model of hygroscopic particle behavior in human airways. Bulletin of Mathematical Biology, 1982, 44, 425-442.
26. Martonen, T. B., Yang, Y., Hwang, D. and Fleming, J. S., Computer simulations of human lung structures for medical applications. Computers in Biology & Medicine, 1995, 25, 431-446.